We are live on ! Find out more
OAM

Ostrum Asset Management Portfolio holdings

AUM $1.78B
1-Year Est. Return 27.8%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+27.8%
3 Year Est. Return
+75.23%
5 Year Est. Return
10 Year Est. Return
AUM
$1.15B
AUM Growth
-$119M
Cap. Flow
-$119M
Cap. Flow %
-10.37%
Top 10 Hldgs %
16.47%
Holding
663
New
9
Increased
134
Reduced
497
Closed
19

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$4.07M
2
TMUS icon
T-Mobile US
TMUS
+$3.79M
3
GDDY icon
GoDaddy
GDDY
+$3.02M
4
GL icon
Globe Life
GL
+$2.92M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$2.78M

Sector Composition

Rank Sector Weight
1 Technology 22.88%
2 Healthcare 17.87%
3 Financials 10.12%
4 Consumer Staples 9.95%
5 Consumer Discretionary 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PANW icon
101
Palo Alto Networks
PANW
$256B
$3.22M 0.28%
18,990
-5,142
-21% -$769K
PLD icon
102
Prologis
PLD
$136B
$3.18M 0.28%
28,342
-1,744
-6% -$193K
LIN icon
103
Linde
LIN
$236B
$3.18M 0.28%
7,248
+287
+4% +$126K
PM icon
104
Philip Morris
PM
$309B
$3.18M 0.28%
31,344
-2,436
-7% -$238K
YUM icon
105
Yum! Brands
YUM
$41.9B
$3.17M 0.28%
23,923
-463
-2% -$63.7K
BSX icon
106
Boston Scientific
BSX
$68.4B
$3.16M 0.28%
41,033
-246
-0.6% -$18K
AON icon
107
Aon
AON
$80.6B
$3.15M 0.28%
10,741
-780
-7% -$231K
UPS icon
108
United Parcel Service
UPS
$88.9B
$3.14M 0.27%
22,946
-873
-4% -$125K
BKNG icon
109
Booking.com
BKNG
$156B
$3.13M 0.27%
19,775
-875
-4% -$130K
CVS icon
110
CVS Health
CVS
$135B
$3.13M 0.27%
53,020
-2,027
-4% -$127K
DIS icon
111
Walt Disney
DIS
$171B
$3.13M 0.27%
31,482
+188
+0.6% +$20.2K
CBRE icon
112
CBRE Group
CBRE
$43.3B
$3.11M 0.27%
34,883
+5,981
+21% +$531K
LRCX icon
113
Lam Research
LRCX
$316B
$3.1M 0.27%
29,110
-190
-0.6% -$18.2K
CDNS icon
114
Cadence Design Systems
CDNS
$91.8B
$3.09M 0.27%
10,043
+92
+0.9% +$27.2K
KEYS icon
115
Keysight
KEYS
$50.7B
$3.05M 0.27%
22,336
-6,274
-22% -$917K
TJX icon
116
TJX Companies
TJX
$179B
$3.04M 0.27%
27,607
-25,385
-48% -$2.56M
O icon
117
Realty Income
O
$61.1B
$3.03M 0.26%
57,325
-2,204
-4% -$118K
AXP icon
118
American Express
AXP
$224B
$3.01M 0.26%
13,019
-664
-5% -$154K
LDOS icon
119
Leidos
LDOS
$14.4B
$2.98M 0.26%
20,400
-8,806
-30% -$1.23M
KMB icon
120
Kimberly-Clark
KMB
$37.6B
$2.97M 0.26%
21,457
-14,274
-40% -$1.91M
SJM icon
121
J.M. Smucker
SJM
$13.5B
$2.94M 0.26%
26,991
-2,098
-7% -$237K
ULTA icon
122
Ulta Beauty
ULTA
$21.8B
$2.9M 0.25%
7,523
-2,624
-26% -$1.07M
HLT icon
123
Hilton Worldwide
HLT
$72.4B
$2.9M 0.25%
13,285
+4,122
+45% +$847K
ACGL icon
124
Arch Capital
ACGL
$36.5B
$2.89M 0.25%
28,635
+152
+0.5% +$14.8K
UNP icon
125
Union Pacific
UNP
$174B
$2.88M 0.25%
12,724
+8,126
+177% +$1.9M

Similar funds

Ostrum Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Ostrum Asset Management held 663 positions worth $1.15B, down 9.4% from $1.27B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Ostrum Asset Management withdrew a net $119M in Q2 2024, closing 19 positions and reducing 497 holdings. Its most notable exit was Globe Life, an estimated $2.92M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ostrum Asset Management opened a new position in CRH worth $293K.

  • Ostrum Asset Management's largest Q2 2024 buy was CRH: 3,911 shares worth $293K.
  • Ostrum Asset Management added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $8.27M increase.
  • Ostrum Asset Management's biggest Q2 2024 reduction was Merck, cutting an estimated $4.07M.
  • Ostrum Asset Management fully exited Globe Life in Q2 2024, selling an estimated $2.92M.
  • Ostrum Asset Management's ten largest holdings make up 16% of its $1.15B portfolio in Q2 2024.
  • Ostrum Asset Management opened 9 new positions and closed 19 in Q2 2024.
  • Ostrum Asset Management's portfolio value fell 9.4% quarter-over-quarter to $1.15B.

Based on Ostrum Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.